1 min read
Add as a preferred source on GooglevTv Therapeutics Posts a $0.94 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate
Cash and cash equivalents were $77.2 million on Sept. 30, 2026, compared with $88.9 million on Dec. 31, 2025.
vTv Therapeutics Inc. (NASDAQ: VTVT) posted a third-quarter GAAP loss of $0.94 per share, beating the estimate by 15 cents, while cash and cash equivalents stood at $77.2 million on Sept. 30, 2026.
The company had $88.9 million in cash and cash equivalents on Dec. 31, 2025.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.